sanofi

Sanofi spokeswoman Emmy Tsui said the company was "committed to the safe and effective use of Eligard" and was reviewing the FDA request.

Sanofi said the acquisition chase is getting more competitive as industry players face the same set of problems.

Just yesterday, Sanofi-Aventis said it was abandoning its drug Acomplia, which had been approved in Europe to treat obesity.

Sanofi and other drugmakers annually produce about 300 million doses of seasonal flu vaccines, the kind used for annual flu shots.

WHO officials "are convinced that the seasonal influenza vaccine is just as important, " the Sanofi Pasteur spokesman says.

Analysts believe Sanofi could be waiting for a final safety review for TroVax, due in the next few months.

Later, Sanofi withdrew its marketing application and said it would resubmit the drug for approval as a diabetes treatment in 2009.

The facility, located in the United States, is owned and operated by sanofi pasteur, which manufactures Fluzone Influenza Virus Vaccine.

Sanofi's share price has come under pressure lately as a result of its acquisition of biotech giant Genzyme.

Biotechnology company Genzyme said Sanofi-Aventis' $69 per share offer undervalues the company.

Sanofi trades at a cheap eight times likely earnings over the next 12 months, with a dividend yield of 3. 6%.

By contrast the priming vaccine, called ALVAC and made by Sanofi Pasteur, a French firm, contains synthetic versions of three HIV genes.

Sanofi-aventis has also submitted a dossier for the STEMI indication in European countries including France, Germany, UK, Italy and Spain.

France's Sanofi-Aventis SA, meanwhile, is carrying out large clinical trials of an oral MS drug called teriflunomide.

Roche, Merck and Sanofi persevered, testing thousands of molecules.

Unfortunately, to make those decisions, Sanofi-Pasteur and its partners need epidemiological information that is currently unavailable.

Sanofi-aventis made its announcement of the donation of 100 million doses of vaccine at the Pacific Health Summit in Seattle, USA.

Today, sanofi pasteur reinvests some 17 percent of its revenues into research and development.

Sanofi said it planned to meet with the FDA about the advisory committees' recommendations.

Bristol-Myers faces a similar dilemma, because Plavix, the blood thinner it sells with Sanofi-Aventis, faces generic competition in 2011.

Just last week, Sanofi received FDA approval to manufacture seasonal flu vaccine at a new facility in Swiftwater, Pa.

If it meets certain milestones, it has the option to force Sanofi to buy it.

He says Sanofi isn't -- 'to my knowledge' -- in active acquisition talks.

The leading flu-vaccine manufacturers include Sanofi and Novartis.

Makers include Sanofi-Aventis (SASY. PA: Quote, Profile, Research) and several generic companies.

Separately, Sanofi said that a new daily treatment for multiple sclerosis taken by mouth met its primary endpoint in a phase III trial.

Europe's Sanofi Pasteur and Novartis are leading producers that use this approach.

Sanofi-aventis, a pharmaceutical firm based in Paris, has been working to develop a new malaria drug for children.

Sanofi is an industry leader in blood-thinning drugs.

However, work has slowed as Acambis is absorbed by a new owner, French vaccine giant Sanofi-Pasteur.

The Emerson and Sanofi real world case illustrated all but which of the following?

Executive Vice President, R&D, Sanofi-Aventis, Paris, France.

Now we did purchase a vaccine, you've probably all heard about it, made by Sanofi-Aventis.

Viehbacher said Sanofi was early to target India and Brazil, before takeover valuations got high.

Mr. Buffett owns about 2% of French drug maker Sanofi, whose products include sleep aid Ambien.

We welcome this very generous gesture by sanofi-aventis.

The first, or prime vaccine, came from the Sanofi Pasteur Company.

Sanofi-Aventis seems set to follow suit.

In June, Frenchdrugmaker Sanofi-Aventis withdrew its diet drug Accompliafrom the review process after an FDA advisory board rejectedit.

A move by Sanofi-Aventis for key US partner Bristol-Myers Squibb has been touted around for many years now.

They all had AF, but their overall level of heart disease was less advanced. Sanofi's U. S.

Sanofi-Aventis produces about 225m doses of seasonal flu vaccine.

Now Sanofi-Aventis is openly talking about making a big acquisition, as is Merck.

The Chinese vaccine firm Sinovac and the French firm Sanofi report similar results.

VaxInnate, Merck and Acambis, which is owned by Sanofi-Aventis, have each run a small test of their M2 vaccines on healthy volunteers.

Buy stock in Sanofi.

American depositary shares of Sanofi-Aventis slipped 0. 1%, while Chattem jumped 33. 10%.

Sanofi has made an offer of $69 a share. Genzyme traded at $83 in 2008.

Sanofi-aventis completed the previously announced acquisition

Sanofi Aventis lotus Hangzhou New Facility Project